# Assessment of a Chronically Implanted Parasternally Delivered EV-ICD Lead (ASCEND EV) Study

> **NCT06592001** · NA · ACTIVE_NOT_RECRUITING · sponsor: **AtaCor Medical, Inc.** · enrollment: 19 (actual)

## Conditions studied

- Ventricular Arrythmia
- Ventricular Fibrillation
- Ventricular Tachycardia

## Interventions

- **DEVICE:** Atala™ lead

## Key facts

- **NCT ID:** NCT06592001
- **Lead sponsor:** AtaCor Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-02-25
- **Primary completion:** 2025-10-27
- **Final completion:** 2028-12-31
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06592001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06592001, "Assessment of a Chronically Implanted Parasternally Delivered EV-ICD Lead (ASCEND EV) Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06592001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*